Literature DB >> 24969487

Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis.

Pingdong Li1, Danni Wang, Haiyang Li, Zhenkun Yu, Xiaohong Chen, Jugao Fang.   

Abstract

The tumor suppressor PTEN is a lipid phosphatase that is found mutated in different types of human cancers. PTEN suppresses cell proliferation by inhibiting the PI3K-Akt signaling pathway at the cell membrane. However, PTEN is also demonstrated to localize in the cell nucleus where it exhibits tumor suppressive activity via a different, unknown mechanism. In this study we report that PTEN also localizes to the nucleolus and that nucleolar PTEN plays an important role in regulating nucleolar homeostasis and maintaining nucleolar morphology. Overexpression of nuclear PTEN in PTEN null cells inhibits Akt phosphorylation and reduces cell size. Knockdown of PTEN in PTEN positive cells leads to nucleolar morphologic changes and an increase in the proportion of cells with a greater number of nucleoli. In addition, knockdown of PTEN in PTEN positive cells increased ribosome biogenesis. These findings expand current understanding of function and relevance of nuclear localized PTEN and provide a foundation for the development of novel therapies targeting PTEN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969487     DOI: 10.1007/s11033-014-3518-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  38 in total

1.  Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells.

Authors:  D J Gillooly; I C Morrow; M Lindsay; R Gould; N J Bryant; J M Gaullier; R G Parton; H Stenmark
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Functional proteomic analysis of human nucleolus.

Authors:  Alexander Scherl; Yohann Couté; Catherine Déon; Aleth Callé; Karine Kindbeiter; Jean-Charles Sanchez; Anna Greco; Denis Hochstrasser; Jean-Jacques Diaz
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Authors:  M M Georgescu; K H Kirsch; P Kaloudis; H Yang; N P Pavletich; H Hanafusa
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 4.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 5.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

6.  Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

Authors:  A Perren; L P Weng; A H Boag; U Ziebold; K Thakore; P L Dahia; P Komminoth; J A Lees; L M Mulligan; G L Mutter; C Eng
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 7.  Nuclear lipids: new functions for old molecules?

Authors:  Alberto M Martelli; G Tabellini; P Borgatti; R Bortul; S Capitani; L M Neri
Journal:  J Cell Biochem       Date:  2003-02-15       Impact factor: 4.429

8.  Isolation and propagation of mouse embryonic fibroblasts and preparation of mouse embryonic feeder layer cells.

Authors:  Anna E Michalska
Journal:  Curr Protoc Stem Cell Biol       Date:  2007-10

9.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.

Authors:  I C Gray; L M Stewart; S M Phillips; J A Hamilton; N E Gray; G J Watson; N K Spurr; D Snary
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more
  17 in total

1.  The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.

Authors:  Patrick Ehm; Marcus M Nalaskowski; Torsten Wundenberg; Manfred Jücker
Journal:  Nucleus       Date:  2015-02-27       Impact factor: 4.197

Review 2.  PTEN proteoforms in biology and disease.

Authors:  Prerna Malaney; Vladimir N Uversky; Vrushank Davé
Journal:  Cell Mol Life Sci       Date:  2017-03-13       Impact factor: 9.261

3.  PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?

Authors:  Lamis Yehia; Charis Eng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

4.  Involvement of the specific nucleolar protein SURF6 in regulation of proliferation and ribosome biogenesis in mouse NIH/3T3 fibroblasts.

Authors:  Anastasiia Moraleva; Charalambos Magoulas; Mikhail Polzikov; Sabine Hacot; Hichem C Mertani; Jean-Jacques Diaz; Olga Zatsepina
Journal:  Cell Cycle       Date:  2017-09-05       Impact factor: 4.534

5.  Novel Assay to Detect RNA Polymerase I Activity In Vivo.

Authors:  Gunes Guner; Paul Sirajuddin; Qizhi Zheng; Baoyan Bai; Alexandra Brodie; Hester Liu; Taija Af Hällström; Ibrahim Kulac; Marikki Laiho; Angelo M De Marzo
Journal:  Mol Cancer Res       Date:  2017-01-23       Impact factor: 5.852

Review 6.  The nuclear phosphoinositide response to stress.

Authors:  Mo Chen; Tianmu Wen; Hudson T Horn; Vishwanatha K Chandrahas; Narendra Thapa; Suyong Choi; Vincent L Cryns; Richard A Anderson
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

7.  Non-canonical role of wild-type SEC23B in the cellular stress response pathway.

Authors:  Darren Liu; Shuai Fu; Lamis Yehia; Pranav Iyer; Charis Eng
Journal:  Cell Death Dis       Date:  2021-03-22       Impact factor: 8.469

Review 8.  Study of PTEN subcellular localization.

Authors:  Angela Bononi; Paolo Pinton
Journal:  Methods       Date:  2014-10-13       Impact factor: 3.608

9.  Molecular Characterization of the Dominant-Negative Role of Cancer-Associated PTEN: Sometimes, Null is Better.

Authors:  Saverio Marchi; Paolo Pinton
Journal:  Front Oncol       Date:  2014-10-10       Impact factor: 6.244

Review 10.  Focus on PTEN Regulation.

Authors:  Miriam Bermúdez Brito; Evangelia Goulielmaki; Evangelia A Papakonstanti
Journal:  Front Oncol       Date:  2015-07-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.